ArticleJournal of gastrointestinal oncology2022

Risk factors and efficacy outcomes of early-onset severe neutropenia due to paclitaxel or nanoparticle albumin-bound paclitaxel combined with ramucirumab in advanced gastric cancer: a multicenter retrospective cohort study.

Yuya Hagiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.